Navigation Links
New Revolutionary Drug Could Stop the Spread of HIV

A new revolutionary drug manufactured by a US biotechnology company could block the spread of HIV, say scientists after finding its benefits in a small-scale human trial. //

Human Immunodeficiency Virus (HIV) steadily weakens the body's immune system until it can no longer fight off infections such as pneumonia, diarrhea, tumours and other illnesses.

Unable to fight back, most people die within three years of the first signs of the disease. Most of all HIV infections have been transmitted through unprotected sexual intercourse with someone who is already infected with the disease.

Panacos Pharmaceuticals in Gaithersburg, Maryland, which is developing PA-457, hopes now to begin trials this month to test how well the drug works in patients whose existing drug regimes are failing, reported the science portal EurekAlert.

About 80 percent of people being treated for HIV show resistance to one or more of their drugs, a spokesman for Panacos said. There are several existing ways of tackling HIV.

Many medications work by blocking reverse transcriptase, an enzyme that enables HIV to replicate within a cell. Others disable protease, which helps to assemble the virus into particles to infect other cells.

The new drug, a derivative of betulinic acid, is a cheap by-product of the paper industry and one of a new class of drugs called maturation inhibitors.

It works by interfering with the production of the capsid protein, a conical "shield" which protects the genetic material of HIV inside it.

The drug is still in its early stages, and will not be generally available for at least three years, he said.

The small human trial of the drug reported that, given on its own, it rapidly clears most HIV from the blood, the study published in the Journal of Virology claimed.

Worldwide, over 36 million people were infected at the end of 2000 with HIV, the most dangerous sexually transmitted infection, with 95 percent of them in developing countries.

(Source: IANS)

Related medicine news :

1. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
2. Revolutionary Pill Cuts Risk of Breast Cancer
3. A Revolutionary New Treatment For Cancer Available In Australia
4. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
5. Revolutionary Net To Control Malaria
6. Revolutionary Net To Control Malaria
7. Revolutionary Eye Cancer Treatment
8. Revolutionary Pill Promises Relief for Hay Fever Sufferers
9. Lean Protein Could Be Key to Obesity Drugs
10. Nasal Spray Could Take Drugs Direct to Brain.
11. Nasal Spray Could Take Drugs Directly to Brain
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... 1Heart Caregiver Services’ Executive Team ... of Philippine American Chambers of Commerce held from November 6-8, 2015 at the ... Services, as an active delegate from the Philippine American Chamber of Commerce of ...
(Date:11/30/2015)... ... 2015 , ... Being a caregiver for someone you love ... Care System, the Caregiver Support Program promotes the health and wellbeing of family ... percent report that their role as a caregiver has created marital strain,” said ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Foundation) released information for caregivers and held two webinars on topics of ‘Medical ... demand free of charge at . , With a loved one's ...
(Date:11/30/2015)... ... ... According to research by the National Association of Dental ... certified or obtain continuing education. To increase awareness of the lack of standards ... inform dentists that the technicians they trust could lack the skills and knowledge ...
(Date:11/30/2015)... ... November 30, 2015 , ... An extensive directory ... specialized and only includes chiropractic clinics in the US. , The team at ... health practitioner when back pain sets in. When people are experiencing back and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon ... today that top-line data from its TELECAST ... etiprate in treating carcinoid syndrome in cancer ... the clinical benefit observed in its pivotal ... as a companion to TELESTAR primarily to ...
(Date:12/1/2015)... 2015 North America ... with analysis and forecast of revenue. --> ... segments the concerned market with analysis and forecast of ... Report "North American Orthobiologics Market by Type (Bone Allograft, ... Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) ...
(Date:12/1/2015)... , December 1, 2015 ... the addition of the  "2016 Shigella ... Innovative Technologies, Competitive Strategies, Emerging Opportunities--US, ... Japan"  report to their offering. ... the addition of the  "2016 Shigella ...
Breaking Medicine Technology: